Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.525 AUD | -1.87% | -0.94% | -21.05% |
04-19 | INOVIQ Concludes Analytical Validation for Ovarian Cancer Blood Test | MT |
04-15 | Fears of Middle East Conflict Escalation Quell Appetite for Australian Shares | MT |
Sales 2024 * | 1.6M 1.05M 83.67M | Sales 2025 * | 6.4M 4.18M 335M | Capitalization | 48.31M 31.56M 2.53B |
---|---|---|---|---|---|
Net income 2024 * | -8M -5.23M -418M | Net income 2025 * | -5M -3.27M -261M | EV / Sales 2024 * | 25.8 x |
Net cash position 2024 * | 7.1M 4.64M 371M | Net cash position 2025 * | 9.4M 6.14M 492M | EV / Sales 2025 * | 6.08 x |
P/E ratio 2024 * |
-5.65
x | P/E ratio 2025 * |
-11.7
x | Employees | 15 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 71.68% |
1 day | -1.87% | ||
1 week | -0.94% | ||
Current month | -13.93% | ||
1 month | -11.76% | ||
3 months | +0.96% | ||
6 months | -10.26% | ||
Current year | -21.05% |
Managers | Title | Age | Since |
---|---|---|---|
Leearne Hinch
CEO | Chief Executive Officer | - | 06/11/16 |
Mark Edwards
DFI | Director of Finance/CFO | - | 01/11/22 |
Gregory Rice
CTO | Chief Tech/Sci/R&D Officer | - | 19/09/21 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 70 | 11-28 | |
Philip Powell
BRD | Director/Board Member | 65 | 17/06/19 |
Geoff Cumming
BRD | Director/Board Member | - | 27/07/20 |
Date | Price | Change | Volume |
---|---|---|---|
26/04/24 | 0.525 | -1.87% | 24,001 |
24/04/24 | 0.535 | +0.94% | 8,037 |
23/04/24 | 0.53 | 0.00% | 101,725 |
22/04/24 | 0.53 | 0.00% | 68,140 |
19/04/24 | 0.53 | -17.19% | 658,199 |
Delayed Quote Australian S.E., April 26, 2024 at 06:42 am
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-21.05% | 31.51M | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- IIQ Stock